Company had adopted a near-zero-tolerance attitude, adding stringent measures had been put in place Sushmi Dey | New Delhi February 25, 2014 Last Updated at 00:04 IST Drug maker Ranbaxy Laboratories is learnt to have seen the exit of 6-10 employees ... Business Standard India, 1 week ago
FDA Takes Action Against Fourth Ranbaxy Site - Contract Pharma, 1 month ago
RANBAXY LABORATORIES LIMITED : FDA Bars Ingredients From Ranbaxy's India Plant - 4 Traders, 1 month ago
3 images for "batamandi"
The US Department of Justice is supplementing financial punishments for pharmaceutical companies violating FDA rules with corporate integrity agreements (CIAs), said the US Assistant Attorney General. In a speech to the CBI Pharmaceutical ...In-Pharmatechnologist, 1 month ago
After imposing a ban on Ranbaxy Laboratories from shipping drugs and raw ingredients from its Toansa plant in Punjab to the US market, the US Food and Drug Administration (USFDA) commissioner Margaret Hamburg is likely to visit India next week to ...Financial Express, 1 month ago
Summary This is the fourth facility of the generic drug manufacturer to be charged by the US health regulator with such violations and the move stops all drug shipments from the company to the US. In a major setback to Ranbaxy Laboratories, ...Indian Express, 1 month ago
By: Dinesh S Thakur We now know that the behaviour that led Ranbaxy to sign the "unprecedented" consent decree in 2012 with the US Food & Drug Administration (FDA) was not limited to just two manufacturing sites. In 2013, the US regulator brought ...Economic Times, 1 month ago Are Indian pharma companies overdosing on lethal drug of fraud? Economic Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!